Thermo Fisher Scientific has welcomed Katrina Downie as Vice President, Commercial BioProduction Group (BPG), North America. In her new role, Downie will support the company’s commercial operations and customer partnerships across its North American bioproduction business.
“Excited for what lies ahead, and working with an outstanding team to support our clients and bring life saving therapies to patients. Look forward to continued partnerships and driving innovation in our field.”
About Katrina Downie
Downie brings more than two decades of experience in life sciences commercial leadership, with a background in bioprocessing, sales strategy, and customer engagement.
Before joining Thermo Fisher Scientific, Downie served as Head of Commercial, BioProcess Solutions Americas at Sartorius. She previously held several leadership positions at MilliporeSigma, including Global Head of Commercial Operations for Life Science Services and Head of Commercial Operations for Process Solution Services across North America and Europe.
Her experience also includes sales and commercial roles at BioReliance. She studied at the University of Strathclyde in Scotland.
About Thermo Fisher Scientific
Thermo Fisher Scientific is a global life sciences company providing analytical instruments, laboratory equipment, bioproduction technologies, and pharmaceutical development services.
Its BioProduction business supports biopharmaceutical manufacturers with technologies and services used throughout biologics development and manufacturing. The company’s North American commercial organization works with customers developing and producing therapies, including biologics and advanced medicines.
